Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate

Jacqueline Ann Nicholas,1 Aaron Lee Boster,1 Jaime Imitola,1,2 Colleen O’Connell,1 Michael Karl Racke1,21Department of Neurology and Multiple Sclerosis Center, 2Department of Neuroscience, The Ohio State University, Columbus, OH, USAAbstract: Dimethyl fumarate (DMF) is the most recent oral...

Full description

Bibliographic Details
Main Authors: Nicholas JA, Boster AL, Imitola J, O'Connell C, Racke MK
Format: Article
Language:English
Published: Dove Medical Press 2014-07-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/design-of-oral-agents-for-the-management-of-multiple-sclerosis-benefit-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/design-of-oral-agents-for-the-management-of-multiple-sclerosis-benefit-peer-reviewed-article-DDDT

Similar Items